Zika vaccine advances to phase 2 testing

A new Zika vaccine shows promising safety and immunogenicity, according to a phase 1 trial by the Vaccine Research Center at the NIH.
Source: AAO

Posted in: Practice News

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553